On August 27, 2025 Adcendo, a clinical-stage biotech company pioneering the development of first and best-in-class ADCs for cancers with a high unmet medical need, reported that management will participate in five upcoming investor conferences in September (Press release, ADCendo, AUG 27, 2025, View Source [SID1234655628]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi 2025 Biopharma Back-to-School Conference
Format: 1×1 meetings
Date: Tuesday, September 2, 2025
Location: Boston, MA

Wells Fargo 2025 Healthcare Conference
Format: Company presentation
Date: Wednesday, September 3, 2025
Time: 3:45 p.m. ET
Location: Boston, MA

Cantor Global Healthcare Conference
Format: 1×1 meetings
Date: Thursday, September 4, 2025
Location: New York, NY

Morgan Stanley 23rd Annual Global Healthcare Conference
Format: Company presentation
Date: Monday, September 8, 2025
Time: 1:50 p.m. ET
Location: New York, NY

Bank of America Healthcare Trailblazers Private Company Conference
Format: 1×1 meetings
Date: Wednesday, September 17, 2025
Location: Boston, MA

On August 27, 2025 AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, reported that Daniel Faga, president and chief executive officer of Anaptys, and/or other members of its executive leadership team, are scheduled to participate in multiple upcoming investor conferences (Press release, AnaptysBio, AUG 27, 2025, View Source [SID1234655507]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cantor Global Healthcare Conference 2025, New York, NY

Format – Fireside chat and one-on-one investor meetings
Date and Time – Wednesday, Sept. 3, 2025 at 8:00am ET / 5:00am PT
2025 Wells Fargo Healthcare Conference, Boston, MA

Format – Fireside chat and one-on-one investor meetings
Date and Time – Thursday, Sept. 4, 2025 at 11:00am ET / 8:00am PT
Stifel 2025 Virtual Immunology and Inflammation Forum, Virtual

Format – Fireside chat and one-on-one investor meetings
Date and Time – Tuesday, Sept. 16, 2025 at 12:00pm ET / 9:00am PT
Live webcasts of the fireside chats will be available on the investor section of the Anaptys website at View Source Replays of the webcasts will be available for at least 30 days following the events.

On August 27, 2025 Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, reported that company management will participate at multiple upcoming investor conferences (Press release, Xencor, AUG 27, 2025, View Source [SID1234655522]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2025 Wells Fargo Healthcare Conference
Date: Wednesday, September 3, 2025
Presentation Time: 3:00 p.m. ET / 12:00 p.m. PT
Cantor Global Healthcare Conference 2025
Date: Thursday, September 4, 2025
Presentation Time: 8:00 a.m. ET / 5:00 a.m. PT

Live webcasts of the presentations will be available under "Events & Presentations" in the Investors section of the Company’s website located at www.xencor.com. Replays of the events will be available on the Xencor website for at least 30 days following the presentations.

On August 27, 2025 enGene Holdings Inc. (Nasdaq: ENGN or "enGene"), a clinical-stage, non-viral gene therapy company, reported that management will participate in the following investor conferences in September (Press release, enGene, AUG 27, 2025, View Source [SID1234655538]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2025 Wells Fargo Healthcare Conference
Date: Wednesday, September 3, 2025
Time: 8:45 a.m. ET

H.C. Wainwright 27th Annual Global Investment Conference
Date: Monday, September 8, 2025
Time: 1:30 p.m. ET

Morgan Stanley 23rd Annual Global Healthcare Conference
Date: Wednesday, September 10, 2025
Time: 1:50 p.m. ET

A live webcast of these events can be accessed under the "Investors" section of the enGene website at www.engene.com and will be archived there for 90 days.

On August 27, 2025 Bio-Techne Corporation (NASDAQ: TECH) reported that it will present at the following investor conferences (Press release, Bio-Techne, AUG 27, 2025, View Source [SID1234655508]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2025 Wells Fargo Healthcare Conference
September 3, 2025
10:15 AM EDT

Baird 2025 Global Healthcare Conference
September 9, 2025
9:05 AM EDT

Morgan Stanley 23rd Annual Global Healthcare Conference
September 10, 2025
10:45 AM EDT

A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne’s Investor Relations website at View Source